Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
7 (1%)
Avoided shortage:
89 (12%)
Resolved:
650 (85%)
766
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
100 (10%)
2 (7%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2023-03-07 | 2023-10-03 | 186407 |
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2024-06-11 | 2025-02-25 | 230092 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Avoided shortage | 2017-03-10 | 2018-09-13 | 197 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2024-01-22 | 2024-05-09 | 216953 |
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2017-07-13 | 2017-10-11 | 15646 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-01-23 | 2023-07-14 | 182205 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2019-05-28 | 2019-07-17 | 85061 |
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2020-01-28 | 2020-02-20 | 104515 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2021-10-13 | 2021-10-26 | 146990 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2025-09-09 | 2026-01-13 | 266856 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2023-08-01 | 2023-10-03 | 200648 |
| MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2019-04-23 | 2019-05-01 | 82204 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2018-02-23 | 2019-01-18 | 40672 |
| MYLAN-MONTELUKAST | 10MG | TABLET | Avoided shortage | 2017-04-07 | 2017-05-05 | 5946 |
| MYLAN-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2017-05-05 | 2018-02-15 | 9241 |
| MYLAN-MONTELUKAST | 10MG | TABLET | Resolved | 2017-04-13 | 2017-12-08 | 7055 |
| MYLAN-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2017-04-13 | 2017-09-08 | 7052 |
| MYLAN-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-07 | 2018-07-11 | 5916 |
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-12-21 | 2018-07-11 | 34097 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-01 | 2023-08-29 | 191357 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6836 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |